Technology News and Research

RSS

Researchers develop techniques to identify evolution of drug resistance strains of malaria

Researchers at Case Western Reserve University developed techniques to quickly identify evolution of drug resistance in strains of malaria. Their goal is to enable the medical community to react quickly to inevitable resistance and thereby save lives while increasing the lifespan of drugs used against the disease.Currently, disease monitoring requires months of clinical trials. The new methods can provide more information in just days, and far cheaper.

3 Aug 2010

MBF announces sale of MSD to Water Street Healthcare Partners

MBF Healthcare Partners, L.P., a middle market healthcare focused private equity firm, announced it has sold Medical Specialties Distributors, LLC, to private equity firm Water Street Healthcare Partners.

2 Aug 2010

XACP invests $4M in $6.1M Series B financing for Health Market Science

Cross Atlantic Capital Partners announced today that it invested $4 million in a $6.1 million Series B financing for Health Market Science, a leading data and analytics provider for the healthcare industry. Cross Atlantic led the round with follow-on investments from other institutional investors, including Edison Venture Fund.

2 Aug 2010

Lakeview Health System selects Lawson Software's multiple enterprise software solutions

Lawson Software today announced that Lakeview Health System has selected multiple enterprise software solutions, including Lawson Enterprise Financial Management, Supply Chain Management, Contract Management, and Budgeting and Planning suites. It also selected Lawson Time & Attendance and Scheduling modules as well as Lawson Business Intelligence.

2 Aug 2010

ARO uses Elekta VMAT system for prostate cancer patients

In the expansive region of Australasia—which includes Australia, New Zealand and neighboring islands—Auckland Radiation Oncology Centre is the first to use Elekta VMAT, treating a patient with prostate cancer using a single 100-second arc of radiation. Such rapid treatments change the entire therapy experience for these patients, who have had to remain completely still for seven minutes during radiation delivery for each of 37 to 39 separate treatment sessions or "fractions."

From Elekta 2 Aug 2010

The NoliWhite Group launches innovative process to integrate iPad on hospital construction sites

The NoliWhite Group, Brentwood-based healthcare facility developers, launched an innovative process that will incorporate the use of Apple's iPad on hospital and other healthcare-related construction sites, officials announced today. The initiative, Project Information Integration, or PI2, is being piloted on the construction of John D. Archbold Memorial Hospital's new North Tower in Thomasville, GA.

2 Aug 2010

Taligen Therapeutics to highlight three pipeline candidates at XXIII ICW

Taligen Therapeutics, a biotechnology company developing therapies that regulate the complement system to treat inflammatory and immune diseases, today announced that preclinical data on three of its pipeline candidates will be highlighted at the XXIII International Complement Workshop taking place August 1-5, 2010, in New York City.

2 Aug 2010

WellDoc DiabetesManager System receives FDA clearance

WellDoc, a healthcare company that develops technology solutions to improve chronic disease management outcomes and reduce healthcare costs, today announced that it has received United States Food and Drug Administration 510(k) clearance to market the WellDoc DiabetesManager System to healthcare providers and their adult patients with type 2 diabetes.

2 Aug 2010

StatRad introduces Stat360 teleradiology solution

StatRad, a leading provider of premier teleradiology services, announces today the introduction of Stat360, the most comprehensive teleradiology solution on the market. Stat360 combines traditional teleradiology services with PACS and live support from virtual radiology assistants with radiologist productivity in mind.

2 Aug 2010

Keane Optimum 3.1 receives Preliminary ARRA IFR Stage 1 certification

Keane, Inc., a U.S.-based IT services and healthcare information technology firm, today announced Keane OptimumTM 3.1 has been inspected by the Certification Commission for Health Information Technology and is certified EHR technology, IFR Stage 1 as part of the organization's Preliminary American Recovery and Reinvestment Act of 2009 certification program.

2 Aug 2010

Explorys secures $2.55M Series B financing from Santé Ventures

Explorys Inc., the leader in cloud computing solutions for healthcare data management, analytics, and outcomes measurement has secured $2.55M Series B financing from Santé Ventures, with follow-on participation from Cleveland Clinic Innovations.

2 Aug 2010

BD announces sale of surgical blades product platform, Ophthalmic Systems unit

BD, a leading global medical technology company, today announced the completion of the sale of its Ophthalmic Systems unit to RoundTable Healthcare Partners and the sale of its surgical blades product platform to one of RoundTable's portfolio companies, Aspen Surgical Products, Inc.

From BD (Becton, Dickinson and Company) 2 Aug 2010

Verizon Business to help courts, prison health care systems with new technology solutions

Courts grappling with jammed dockets and prisons struggling to handle inmate health care issues can now put the power of video collaboration to work, with a new, tailored set of technology solutions and professional consulting services from Verizon Business.

2 Aug 2010

Phase I/II clinical study data of OncoVEXGM-CSF for head and neck cancer published in Clinical Cancer Research

BioVex Inc, a company developing new generation biologics for the treatment of cancer and prevention of infectious disease, announces that the data from its completed Phase I/II clinical study of OncoVEXGM-CSF for the first line treatment of head and neck cancer is being published today in Clinical Cancer Research, an ASCO publication.

2 Aug 2010

Study: hGH linked to PROLOR's CTP technology increases half-life, bioactivity

PROLOR Biotech, Inc., a company developing next generation biobetter therapeutic proteins, today reported publication of a preclinical study in the current on-line edition of the journal Endocrinology showing that human growth hormone (hGH) linked to PROLOR's carboxyl terminal peptide (CTP) technology has significantly increased half-life and bioactivity compared to commercially available hGH. The publication, which is authored by PROLOR researchers, will also be included in the September print edition of Endocrinology.

2 Aug 2010

Henry Schein second-quarter 2010 net sales increase 15.1% to $1.8 billion

Henry Schein, Inc., the largest provider of healthcare products and services to office-based practitioners, today reported record financial results for the quarter ended June 26, 2010.

2 Aug 2010

HDL does not predict heart attack risk after dramatic statin therapy: Study

People with high levels of "good cholesterol," HDL-C, tend to have fewer heart attacks, but HDL-C may offer little protection to people who take statins to lower harmful LDL cholesterol, researchers reported July 21. At Brigham and Women's Hospital in Boston, Dr. Paul Ridker and colleagues analyzed a large study of healthy people who took the statin CRESTOR® (rosuvastatin calcium) to prevent heart attacks. They found that in this group, having high HDL-C was a bad predictor of heart attack risk.

2 Aug 2010

Rethink Autism, eSchool News offer webinar to show how schools can save costs using new technology

Public school administrators are facing the prospect of deeper budget cuts in cities and states nationwide. Meanwhile, schools with fewer resources are challenged to comply with the federal Individuals with Disabilities Education Act, which guarantees "free appropriate" education to all disabled students, including the growing number of students with an Autism Spectrum Disorder. In addition, parents are pressuring schools to either comply with the IDEA or face legal action.

2 Aug 2010

Life Technologies launches new assay to detect deadly strain of E. coli

Life Technologies, a provider of innovative life science solutions, announced at the International Association of Food Protection annual meeting the launch of the MicroSEQ E. coli O157:H7 assay, designed to detect the deadly strain of Escherichia coli (E. coli), using the company's industry-leading real-time PCR technology.

2 Aug 2010

DAIICHI SANKYO EUROPE adopts DATATRAK's eClinical platform for cardiovascular clinical study

DATATRAK International, Inc., a technology and services company focused on global eClinical solutions for the clinical trials industry, today announced that DAIICHI SANKYO EUROPE GmbH has selected DATATRAK's eClinical™ platform for a cardiovascular clinical study encompassing 80 sites and 1,200 patients across Europe.

2 Aug 2010

Technology News and Research

Researchers develop techniques to identify evolution of drug resistance strains of malaria

MBF announces sale of MSD to Water Street Healthcare Partners

XACP invests $4M in $6.1M Series B financing for Health Market Science

Lakeview Health System selects Lawson Software's multiple enterprise software solutions

ARO uses Elekta VMAT system for prostate cancer patients

The NoliWhite Group launches innovative process to integrate iPad on hospital construction sites

Taligen Therapeutics to highlight three pipeline candidates at XXIII ICW

WellDoc DiabetesManager System receives FDA clearance

StatRad introduces Stat360 teleradiology solution

Keane Optimum 3.1 receives Preliminary ARRA IFR Stage 1 certification

Explorys secures $2.55M Series B financing from Santé Ventures

BD announces sale of surgical blades product platform, Ophthalmic Systems unit

Verizon Business to help courts, prison health care systems with new technology solutions

Phase I/II clinical study data of OncoVEXGM-CSF for head and neck cancer published in Clinical Cancer Research

Study: hGH linked to PROLOR's CTP technology increases half-life, bioactivity

Henry Schein second-quarter 2010 net sales increase 15.1% to $1.8 billion

HDL does not predict heart attack risk after dramatic statin therapy: Study

Rethink Autism, eSchool News offer webinar to show how schools can save costs using new technology

Life Technologies launches new assay to detect deadly strain of E. coli

DAIICHI SANKYO EUROPE adopts DATATRAK's eClinical platform for cardiovascular clinical study

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News